Total raised
—
Stage
Pre-Funding
Founded
2022
Headcount
2
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
BSD SCIENCE is a biotech company that has developed a unique oral dosage form designed for controlled release (CR) of lipophilic drugs, in order to achieve long duration of effect, less adverse effects and higher compliance to treatment.
The platform is suitable for lipophilic molecules used in the Medical Cannabis, Pharma industry and Dietary Supplement markets. During 2022, the company completed a POC PK animals study, where promising results were achieved, and U.S. Provisional Patent Application was submitted. BSD SCIENCE plans to move on towards human PK study.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of BSD SCIENCE's technology?
- BSD SCIENCE is a biotech company focused on developing a unique oral dosage form for controlled release (CR) of lipophilic drugs.
- When was BSD SCIENCE founded?
- BSD SCIENCE was founded in January 2022.
- What significant development did BSD SCIENCE achieve in 2022?
- In 2022, BSD SCIENCE completed a Proof-of-Concept (POC) PK animal study, which yielded promising results.
- Did BSD SCIENCE file any patent applications in 2022?
- Yes, in 2022, BSD SCIENCE submitted a U.S. Provisional Patent Application.
- What is the next planned step for BSD SCIENCE following their animal study?
- BSD SCIENCE plans to proceed with a human PK study.
- Which markets does BSD SCIENCE's platform target?
- The platform developed by BSD SCIENCE is suitable for lipophilic molecules used in the Medical Cannabis, Pharma industry, and Dietary Supplement markets.
- What is the current funding stage of BSD SCIENCE?
- BSD SCIENCE is currently in the Pre-Funding stage.
- How many employees does BSD SCIENCE currently have?
- BSD SCIENCE currently has 2 employees.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
pharmaceuticalsbiotechnologydrug-deliverytreatmentsmedical-cannabis